Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quintiles and ArgoMed to sell prostate device:

This article was originally published in Clinica

Executive Summary

Quintiles Transnational has agreed a commercialisation alliance with Israeli company ArgoMed to develop its FDA-approved Thermoflex water-induced thermotherapy system to treat benign prostatic hyperplasia (BPH). Quintiles corporate ventures business, PharmaBio Development, will provide credit for ArgoMed to organise a US sales force and market the device. In addition, PharmaBio will take equity in the company, while Innovex, Quintiles' commercialisation unit, will deploy the sales force where it is required by ArgoMed. Innovex claims that it has created 19 sales forces and launched 19 new products over the past five years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071186

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel